PMID: 40269251 Bone Res The HOXC10/NOD1/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer
projected oral semaglutide to be cost-effective, while studies in the US and Denmark, published by the Institute for Clinical and Economic Review and Ehlers et al., respectively, predicted that oral semaglutide was not cost-effective [14, 15, 48, 50]
Jabbour S, Paik JS, Aleppo G, Sharma P, Gomez Valderas E, Benneyworth BD
Pei et al., 2014
Ultimately, we dont yet know whether generic semaglutide will be covered by insurance, and it will likely depend on what the medication is prescribed for and whether there are any policy changes about coverage for weight loss medications, which is currently not required by law
If the treat you want is something youll truly remember in two weeks, then go for it